Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
Moodys
McKinsey
Medtronic
Mallinckrodt
AstraZeneca

Last Updated: October 18, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SELEGILINE

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Selegiline

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000188 Selegiline in Treatment of Cocaine Dependence - 2 Completed National Institute on Drug Abuse (NIDA) Phase 2 1994-09-01 The purpose of this study is to assess selegiline as a pharmacotherapy for cocaine dependence.
NCT00000188 Selegiline in Treatment of Cocaine Dependence - 2 Completed University of Pennsylvania Phase 2 1994-09-01 The purpose of this study is to assess selegiline as a pharmacotherapy for cocaine dependence.
NCT00000201 Pharmacological Modulation of Cocaine Effects - 1 Completed Johns Hopkins University Phase 2 1969-12-31 The purpose of this study is to conduct human laboratory studies of possible cocaine interactions with various potential treatment medications.
NCT00000201 Pharmacological Modulation of Cocaine Effects - 1 Completed National Institute on Drug Abuse (NIDA) Phase 2 1969-12-31 The purpose of this study is to conduct human laboratory studies of possible cocaine interactions with various potential treatment medications.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Selegiline

Condition Name

Condition Name for Selegiline
Intervention Trials
Parkinson's Disease 6
Cocaine-Related Disorders 5
HIV Infections 3
Parkinson Disease 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Selegiline
Intervention Trials
Parkinson Disease 10
Cocaine-Related Disorders 5
HIV Infections 4
Cognition Disorders 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Selegiline

Trials by Country

Trials by Country for Selegiline
Location Trials
United States 114
Iran, Islamic Republic of 1
Canada 1
Germany 1
Spain 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Selegiline
Location Trials
California 14
Maryland 12
Florida 7
Texas 6
New York 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Selegiline

Clinical Trial Phase

Clinical Trial Phase for Selegiline
Clinical Trial Phase Trials
Phase 4 10
Phase 3 3
Phase 2 15
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Selegiline
Clinical Trial Phase Trials
Completed 28
Terminated 2
Unknown status 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Selegiline

Sponsor Name

Sponsor Name for Selegiline
Sponsor Trials
National Institute on Drug Abuse (NIDA) 11
National Institute of Neurological Disorders and Stroke (NINDS) 6
Somerset Pharmaceuticals 5
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Selegiline
Sponsor Trials
Other 20
NIH 19
Industry 8
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Merck
Mallinckrodt
Moodys
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.